Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT Dose-Response in Healthy Subjects
NCT05384678Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Nov 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DMT in major depressive disorder (MDD), sponsored by University Hospital Basel. Started Nov 2022; status: completed.
02
Drugs
DMT
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05384678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05384678.